In accordance with Listing Rule 17.1 the Company requests an immediate trading halt on its securities (PTX and PTXO) pending the release of an announcement to the market in relation to results from the Company’s Phase 1b Breast Cancer trial.
The trading halt is requested until the earlier of the release of the announcement or prior to commencement of trading on Thursday 6 April 2017
PTX Price at posting:
9.8¢ Sentiment: Buy Disclosure: Held
